STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. ADTX
  4. [EFFECT] Aditxt, Inc. SEC Filing

[EFFECT] Aditxt, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 30, 2025 4:30 P.M.
Form: S-1
CIK: 0001726711
Company Name: Aditxt, Inc.
File Number: 333-288211

Source: View Original Filing on SEC EDGAR

Stock ADTX logo
Aditxt Inc

NASDAQ:ADTX

ADTX Rankings

#6786 Ranked by Market Cap
N/A Ranked by Dividends

ADTX Latest News

Nov 18, 2025
Aditxt Provides Updates on its Growth Vision for bitXbio™, Planned Digital Asset Treasury, Pearsanta’s Planned IPO, And Evofem’s Plan to Regain a National Listing
Oct 29, 2025
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025
Oct 27, 2025
Aditxt Subsidiary Pearsanta Begins Enrollment in First Human Study of Blood-Based Diagnostic for Endometriosis, a Condition Affecting 190 Million Women Worldwide and Representing a $1.45 Billion Global Market
Oct 20, 2025
Evofem Announces Voting Results from Special Meeting of Stockholders
Sep 11, 2025
Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms

ADTX Latest SEC Filings

Nov 18, 2025
[8-K] Aditxt, Inc. Reports Material Event
Nov 17, 2025
[10-Q] Aditxt, Inc. Quarterly Earnings Report
Nov 17, 2025
[NT 10-Q] Aditxt, Inc. SEC Filing
Oct 31, 2025
[8-K] Aditxt, Inc. Reports Material Event
Oct 20, 2025
[8-K] Aditxt, Inc. Reports Material Event

ADTX Stock Data

1.74M
559.44k
0.79%
2.64%
Biotechnology
Pharmaceutical Preparations
Link
United States
RICHMOND